Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies.
Saved in:
| Title: | Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies. |
|---|---|
| Authors: | Paryani M; Institute of Pharmacy, Nirma University, Gujarat, 382481, India., Gupta N; Institute of Pharmacy, Nirma University, Gujarat, 382481, India., Jain SK; India Operations, Amneal Pharmaceuticals, Ahmedabad, Gujarat, India., Butani S; Institute of Pharmacy, Nirma University, Gujarat, 382481, India. shital.butani@nirmauni.ac.in. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Jun; Vol. 398 (6), pp. 6597-6615. Date of Electronic Publication: 2025 Jan 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1912 |
|---|---|
| DOI: | 10.1007/s00210-025-03826-4 |
